For the Inventor, By the Inventor

Enter assignee name

Dallas, TX, United States of America

Access Pharmaceuticals, Inc.

USPTO Granted Patents = 16

% Expired Patents = 18.8

CIPO Patents = 1

EPO Patents = 1

Forward Citations = 740

Loading Chart...

Loading Chart...

22 inventors (with patents filed for the assignee):

David P Nowotnik (5 out of 16 patents)

David F Ranney (5 out of 12 patents)

Donald R Stewart (3 out of 4 patents)

4. Paul R Sood (2 out of 5 patents)

5. Mark B Knudson (2 out of 127 patents)

6. Jeremy E Jacob (2 out of 2 patents)

7. Christiane M Baud (2 out of 2 patents)

8. Ruth Duncan (2 out of 11 patents)

9. Sergiy Victorovych Shevchuk (2 out of 2 patents)

10. Julio M Fernandez (2 out of 5 patents)

11. Evagoras G Evagorou (2 out of 2 patents)

12. Paolo Ferruti (1 out of 28 patents)

13. Elisabetta Gianasi (1 out of 2 patents)

14. Daniel G Moro (1 out of 4 patents)

15. K Bruce Thurmond (1 out of 1 patent)

16 patents: Sort by Forward Citations

1. 7754684 - Macromolecular platinum chelates (2010-07-13),

2. 7547433 - Liquid formulations for the prevention and treatment of mucosal diseases and disorders (2009-06-16),

3. 7544348 - Liquid formulations for the prevention and treatment of mucosal diseases and disorders (2009-06-09),

4. 7166733 - O,O'-Amidomalonate and N,O-Amidomalonate platinum complexes (2007-01-23),

5. 6692734 - N,O-amidomalonate platinum complexes (2004-02-17),

6. 6585997 - Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds (2003-07-01),

7. 6521431 - Biodegradable cross-linkers having a polyacid connected to reactive groups for cross-linking polymer filaments (2003-02-18),

8. 6106866 - In vivo agents comprising cationic drugs, peptides and metal chelators (2000-08-22),

9. 5985916 - Polymer-platinum compounds (1999-11-16),

10. 5965118 - Polymer-platinum compounds (1999-10-12),

11. 5820879 - Method of delivering a lipid-coated condensed-phase microparticle (1998-10-13),

12. 5753261 - Lipid-coated condensed-phase microparticle composition (1998-05-19),

13. 5707604 - Vivo agents comprising metal-ion chelates with acidic saccharides and (1998-01-13),

14. 5672334 - Invivo agents comprising cationic metal chelators with acidic (1997-09-30),

15. 5336762 - Polychelating agents for image and spectral enhancement (and spectral (1994-08-09),

Access Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of proprietary products for the treatment and supportive care of cancer patients. The company's lead product is MuGard, an FDA-approved, alcohol-free, mucoadhesive oral wound rinse for the management of oral mucositis, a common side effect of chemotherapy and radiation therapy. Access Pharmaceuticals is dedicated to improving the quality of life for cancer patients through innovative drug delivery technologies.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

16 Patents

#128 in Dallas, TX

#1,211 in Texas

#19,887 in US

#37,739 in the World

Dallas, TX, United States of America

Access Pharmaceuticals, Inc.

Forward Citations = 740

22 inventors:

David P Nowotnik (5 out of 16 patents)

David F Ranney (5 out of 12 patents)

Donald R Stewart (3 out of 4 patents)

4. Paul R Sood (2 out of 5 patents)

5. Mark B Knudson (2 out of 127 patents)

Please report any incorrect information to [email protected]

Loading…